Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
Overview
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3933 Cr | ₹8114 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 32% | 21% |
Expense Ratio | 1.94 | 1.82 |
Manager | Pradeep Kesavan | Sailesh Raj Bhan |
ISIN Code | INF200K01446 | INF204K01968 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 1.09% | -0.91% |
6 Month | 6.1% | 5.43% |
1 Year | 4.57% | -1.62% |
3 Year | 26.06% | 22.08% |
5 Year | 19.48% | 17.44% |
SIP Return Analysis
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | 1.91% | -0.13% |
1 Year | 9.01% | 4.99% |
3 Year | 23.08% | 18.87% |
5 Year | 20.8% | 17.35% |
Rolling Lumpsum Returns
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 15.65% | 16.99% |
3 Year | 17.81% | 20.8% |
5 Year | 12.99% | 20.54% |
Risk Management
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 14.07% | 15.22% |
Sharp | 1.18% | 0.89% |
Beta | 0.84% | 0.91% |
Alpha | 3.58% | -0.46% |
Fund Managers
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Pradeep Kesavan | Sailesh Raj Bhan |
Total AUM | ₹434274 Cr | ₹96086 Cr |
Funds Managed | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Market Cap
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 13.04 | 1.52 |
Mid Cap | 27.23 | 33.86 |
Small Cap | 34.17 | 31.35 |
Large Cap | 25.56 | 33.27 |
Sector Allocation
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 3.64 | 0.53 |
Basic Materials | 5.69 | - |
Healthcare | 90.67 | 99.47 |
Top Comparisons
LIC MF Large & Mid Cap Fund Regular-Growth
3Y Returns16.89%
LIC MF Large & Mid Cap Fund-Regular Plan-Growth
3Y Returns16.89%
SBI Magnum Childrens Benefit Fund - Savings Plan - REGULAR PLAN - GROWTH
3Y Returns12.22%
Axis Children's Fund - Lock in - Growth
3Y Returns10.73%
Franklin U.S. Opportunities Equity Active FOF - Regular - Growth
3Y Returns24.65%
DSP Global Innovation Fund of Fund - Regular - Growth
3Y Returns33.91%
Nippon India Aggressive Hybrid Fund - Regular - Growth
3Y Returns16.57%
Canara Robeco Equity Hybrid Fund - Regular Plan - Growth Option
3Y Returns14.55%